Literature DB >> 14409042

The innocuousness and possible therapeutic use of aerosol amphotericin-B.

K H KILBURN.   

Abstract

Entities:  

Keywords:  FUNGICIDES/pharmacology

Mesh：

Substances：

Year:  1959        PMID： 14409042     DOI： 10.1164/arrd.1959.80.3.441

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  4 in total

Review 1.  Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients.

Authors:  J Beyer; S Schwartz; V Heinemann; W Siegert
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

2.  Invasive pulmonary aspergillosis in a non-immunosuppressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin.

Authors:  S Rodenhuis; F Beaumont; H F Kauffman; H J Sluiter
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

3.  Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis.

Authors:  H J Schmitt; E M Bernard; M Häuser; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

Review 4.  Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis.

Authors:  J Beyer; S Schwartz; G Barzen; G Risse; K Dullenkopf; C Weyer; W Siegert
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.